Blue Crest Capital Management LTD Matinas Bio Pharma Holdings, Inc. Transaction History

Blue Crest Capital Management LTD

  • $1.62 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$0.53 - $1.11 $41,255 - $86,402
-77,840 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$0.35 - $0.92 $59,296 - $155,866
-169,420 Reduced 68.52%
77,840 $72,000
Q2 2018

Aug 14, 2018
BUY
$0.42 - $0.74 $103,849 - $182,972
247,260 New
247,260 $107,000

Others Institutions Holding MTNB

# of Institutions
6
Shares Held
3.52M
Call Options Held
0
Put Options Held
0
View Full List

About Matinas BioPharma Holdings, Inc.

MTNB Quotes by TradingView
  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $130M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Blue Crest Capital Management LTD Portfolio

Follow Blue Crest Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Blue Crest Capital Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email